Healthcare provider profile · identity verified

Michael R Mcleod, M.D.

Allopathic & Osteopathic Physicians|Family Medicine · CROCKETT, TX · NPI 1104897750

Profile state: payments and partd Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

CMS Open Payments records show Michael R Mcleod, M.D. received $45.28 in general payments during 2025 across 2 reported records.

Verona Pharma, Inc. accounted for 63.0% of that reported general-payment amount.

The Open Payments records used for this analysis explicitly named 2 associated products.

A separate comparison found the same explicitly named product in public Medicare Part D data: Jardiance.

Boehringer Ingelheim Pharmaceuticals, Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported JARDIANCE as an associated drug or biological on 123636 records involving 49438 distinct recipient NPIs. Public Medicare Part D data also shows 49 claims for Jardiance by this doctor in 2024.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

$45.28

2 reported records · 2 companies

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Who paid this doctor?

Companies in 2025 General Payments

Reported company	Canonical company	Amount	Share	Records	Year
Verona Pharma, Inc.	Unresolved — no canonical attribution shown	$28.51	63.0%	1	2025
Boehringer Ingelheim Pharmaceuticals, Inc.	Unresolved — no canonical attribution shown	$16.77	37.0%	1	2025

What were the payments for?

Payment categories

Category	Amount	Records
Food and Beverage	$45.28	2

A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.

Analysis 1 · Payment-linked products

Products named in Open Payments records

Reported product	Type	Reported company	Related amount*	Records	Year
Ohtuvayre Normalized: ohtuvayre	Drug	Verona Pharma, Inc.	$28.51	1	2025
Source payment records 2025-09-23 · Verona Pharma, Inc. · $28.51 · Open Payments source
JARDIANCE Normalized: jardiance	Drug	Boehringer Ingelheim Pharmaceuticals, Inc.	$16.77	1	2025
Source payment records 2025-08-06 · Boehringer Ingelheim Pharmaceuticals, Inc. · $16.77 · Open Payments source

* Product-associated amounts are non-additive because one payment record may name more than one product.

These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.

Public prescribing for products named in payments

Open Payments product	Payment year	Part D brand	Part D year	Claims	Match method	Source
JARDIANCE jardiance	2025	Jardiance	2024	49 Beneficiary count suppressed	exact normalized	Medicare Part D

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

Paying company	Payment year	Drug reported by same entity	Open Payments evidence	Part D	Claims	Beneficiaries
Boehringer Ingelheim Pharmaceuticals, Inc. Exact reporting entity; no affiliate inference	2025	JARDIANCE open payments reported associated product	CMS Open Payments — General Payments 123636 supporting records · 49438 recipient NPIs · example record 1221811583	Jardiance · 2024 Exact normalized brand match · 1 Part D row	49	suppressed by CMS

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	677	127
Atorvastatin Calcium	Atorvastatin Calcium	619	148
Amlodipine Besylate	Amlodipine Besylate	607	135
Gabapentin	Gabapentin	568	105
Furosemide	Furosemide	467	101
Pantoprazole Sodium	Pantoprazole Sodium	441	100
Losartan Potassium	Losartan Potassium	407	97
Metformin Hcl Er	Metformin Hcl	390	74
Metoprolol Succinate	Metoprolol Succinate	386	88
Lisinopril	Lisinopril	341	78
Prednisone	Prednisone	325	201
Celecoxib	Celecoxib	324	79
Rosuvastatin Calcium	Rosuvastatin Calcium	264	57
Montelukast Sodium	Montelukast Sodium	232	55
Trazodone Hcl	Trazodone Hcl	230	45
Potassium Chloride	Potassium Chloride	228	57
Clopidogrel	Clopidogrel Bisulfate	214	52
Glimepiride	Glimepiride	212	42
Tamsulosin Hcl	Tamsulosin Hcl	211	50
Carvedilol	Carvedilol	207	40
Omeprazole	Omeprazole	204	51
Meloxicam	Meloxicam	202	45
Tramadol Hcl	Tramadol Hcl	197	67
Albuterol Sulfate Hfa	Albuterol Sulfate	190	50
Allopurinol	Allopurinol	189	41
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	183	35
Alprazolam	Alprazolam	178	43
Duloxetine Hcl	Duloxetine Hcl	157	27
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	156	34
Sertraline Hcl	Sertraline Hcl	147	29
Eliquis	Apixaban	142	23
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	134	35
Escitalopram Oxalate	Escitalopram Oxalate	127	19
Azithromycin	Azithromycin	126	110
Pregabalin	Pregabalin	123	20
Buspirone Hcl	Buspirone Hcl	115	21
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	114	32
Metformin Hcl	Metformin Hcl	110	27
Hydrochlorothiazide	Hydrochlorothiazide	106	34
Paroxetine Hcl	Paroxetine Hcl	106	24
Ropinirole Hcl	Ropinirole Hcl	105	17
Tizanidine Hcl	Tizanidine Hcl	105	28
Simvastatin	Simvastatin	96	21
Fluticasone Propionate	Fluticasone Propionate	94	31
Metoprolol Tartrate	Metoprolol Tartrate	93	26
Ozempic	Semaglutide	91	19
Pioglitazone Hcl	Pioglitazone Hcl	91	24
Famotidine	Famotidine	90	20
Ezetimibe	Ezetimibe	85	13
Xarelto	Rivaroxaban	81	suppressed
Spironolactone	Spironolactone	79	18
Citalopram Hbr	Citalopram Hydrobromide	74	15
Fluconazole	Fluconazole	74	40
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	72	59
Nitrofurantoin	Nitrofurantoin Macrocrystal	71	38
Esomeprazole Magnesium	Esomeprazole Magnesium	70	15
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	68	27
Estradiol	Estradiol	67	15
Lorazepam	Lorazepam	66	11
Risperidone	Risperidone	66	15
Finasteride	Finasteride	63	17
Fluoxetine Hcl	Fluoxetine Hcl	61	suppressed
Propranolol Hcl Er	Propranolol Hcl	59	15
Pravastatin Sodium	Pravastatin Sodium	55	13
Metolazone	Metolazone	54	19
Oxybutynin Chloride Er	Oxybutynin Chloride	54	16
Fenofibrate	Fenofibrate Nanocrystallized	52	12
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	52	13
Levofloxacin	Levofloxacin	52	47
Ondansetron Odt	Ondansetron	52	31
Ciprofloxacin Hcl	Ciprofloxacin Hcl	50	42
Doxycycline Hyclate	Doxycycline Hyclate	49	45
Jardiance	Empagliflozin	49	suppressed
Clonazepam	Clonazepam	48	suppressed
Methotrexate	Methotrexate Sodium	47	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	47	14
Digoxin	Digoxin	45	suppressed
Hydralazine Hcl	Hydralazine Hcl	45	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	44	14
Atenolol	Atenolol	44	suppressed
Donepezil Hcl	Donepezil Hcl	44	suppressed
Hydrocortisone	Hydrocortisone	44	25
Clonidine Hcl	Clonidine Hcl	43	12
Bupropion Xl	Bupropion Hcl	42	suppressed
Mupirocin	Mupirocin	41	suppressed
Synthroid	Levothyroxine Sodium	41	12
Glipizide Er	Glipizide	39	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	38	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	37	suppressed
Valacyclovir	Valacyclovir Hcl	37	22
Clindamycin Hcl	Clindamycin Hcl	36	25
Farxiga	Dapagliflozin Propanediol	36	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	36	11
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	35	12
Mirtazapine	Mirtazapine	35	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	35	suppressed
Glipizide	Glipizide	34	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	34	suppressed
Levetiracetam	Levetiracetam	34	suppressed
Topiramate	Topiramate	34	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	33	suppressed
Ramipril	Ramipril	32	suppressed
Amiodarone Hcl	Amiodarone Hcl	31	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	30	suppressed
Memantine Hcl	Memantine Hcl	30	suppressed
Cephalexin	Cephalexin	29	22
Fenofibrate	Fenofibrate	29	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	29	suppressed
Warfarin Sodium	Warfarin Sodium	29	suppressed
Cilostazol	Cilostazol	27	suppressed
Methocarbamol	Methocarbamol	27	suppressed
Tradjenta	Linagliptin	27	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	26	suppressed
Levemir Flexpen	Insulin Detemir	26	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	25	suppressed
Nifedipine Er	Nifedipine	25	suppressed
Propranolol Hcl	Propranolol Hcl	25	suppressed
Spiriva Handihaler	Tiotropium Bromide	25	suppressed
Baclofen	Baclofen	24	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	24	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	24	suppressed
Ketoconazole	Ketoconazole	24	suppressed
Diclofenac Sodium	Diclofenac Sodium	23	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	23	suppressed
Symbicort	Budesonide/Formoterol Fumarate	23	suppressed
Divalproex Sodium	Divalproex Sodium	22	suppressed
Mounjaro	Tirzepatide	22	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	21	suppressed
Verapamil Er	Verapamil Hcl	21	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	20	suppressed
Ventolin Hfa	Albuterol Sulfate	20	suppressed
Neomycin-Polymyxin-Dexameth	Neomycin/Polymyxin B/Dexametha	19	14
Chlorthalidone	Chlorthalidone	18	suppressed
Enulose	Lactulose	18	suppressed
Tresiba Flextouch U-100	Insulin Degludec	18	suppressed
Ibuprofen	Ibuprofen	17	suppressed
Levemir	Insulin Detemir	17	suppressed
Megestrol Acetate	Megestrol Acetate	17	suppressed
Memantine Hcl Er	Memantine Hcl	17	suppressed
Testosterone Cypionate	Testosterone Cypionate	17	suppressed
Bupropion Hcl Sr	Bupropion Hcl	16	suppressed
Lansoprazole	Lansoprazole	16	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	16	suppressed
Sucralfate	Sucralfate	16	suppressed
Temazepam	Temazepam	16	suppressed
Alendronate Sodium	Alendronate Sodium	15	suppressed
Diazepam	Diazepam	15	suppressed
Loperamide	Loperamide Hcl	15	suppressed
Lovastatin	Lovastatin	15	suppressed
Midodrine Hcl	Midodrine Hcl	15	suppressed
Breo Ellipta	Fluticasone/Vilanterol	14	suppressed
Humalog Kwikpen U-100	Insulin Lispro	14	suppressed
Morphine Sulfate Er	Morphine Sulfate	14	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	14	12
Nystatin	Nystatin	14	suppressed
Semglee (Yfgn) Pen	Insulin Glargine-Yfgn	14	suppressed
Verapamil Sr	Verapamil Hcl	14	suppressed
Clorazepate Dipotassium	Clorazepate Dipotassium	13	suppressed
Colchicine	Colchicine	13	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	13	suppressed
Estradiol (Once Weekly)	Estradiol	13	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	13	suppressed
Methadone Hcl	Methadone Hcl	13	suppressed
Nexium	Esomeprazole Magnesium	13	suppressed
Ondansetron Hcl	Ondansetron Hcl	13	11
Symtuza	Darunavir/Cob/Emtri/Tenof Alaf	13	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	13	suppressed
Alcohol Pads	Alcohol Antiseptic Pads	12	suppressed
Armour Thyroid	Thyroid,pork	12	suppressed
Dexamethasone	Dexamethasone	12	suppressed
Dexlansoprazole Dr	Dexlansoprazole	12	suppressed
Dofetilide	Dofetilide	12	suppressed
Entresto	Sacubitril/Valsartan	12	suppressed
Fenofibrate	Fenofibrate,micronized	12	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	12	suppressed
Lamotrigine	Lamotrigine	12	suppressed
Meclizine Hcl	Meclizine Hcl	12	suppressed
Oxycodone Hcl	Oxycodone Hcl	12	suppressed
Trintellix	Vortioxetine Hydrobromide	12	suppressed
Valsartan	Valsartan	12	suppressed
Ziprasidone Hcl	Ziprasidone Hcl	12	suppressed
Acyclovir	Acyclovir	11	suppressed
Dabigatran Etexilate	Dabigatran Etexilate Mesylate	11	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	11	suppressed
Potassium Citrate Er	Potassium Citrate	11	suppressed
Rasagiline Mesylate	Rasagiline Mesylate	11	suppressed
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	$45.28 · 2 records	Verona Pharma, Inc.	JARDIANCE, Ohtuvayre	1	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

What role, if any, does Jardiance play in your treatment recommendations for me?
How do you evaluate evidence when you have a financial relationship with Boehringer Ingelheim Pharmaceuticals, Inc.?
Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error